FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:202-203 January 8, 2004 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Second edition. Edited by Pierre A. Clavien, Yuman Fong, H. Kim Lyerly, Michael A. Morse, and Alan P. Venook. 482 pp., illustrated. Sudbury, Mass., Jones and Bartlett, 2004. $174.95. ISBN 0-7637-1857-2.

Hepatocellular carcinoma, although uncommon in the United States, is one of the few forms of cancer that is rising in incidence in the developed Western world. The second edition of this book consists of 36 chapters that are printed on nearly 500 pages of glossy paper. The editor-in-chief, Pierre-Alain Clavien of Switzerland, has four associate editors from the United States and 63 authors and coauthors from around the world. The book emphasizes the management of hepatocellular carcinoma in Western countries, as distinct from Africa and Asia (including Japan), where the disease is more common but seems to present differently. The . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.